Swan Capital’s Merck MRK Stock Holding History

Swan Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55.3K	Sell	460 -113	-20%	-$13K	0.02%	74
2025 Q4	$60.3K	Buy	573 +16	+3%	+$1.5K	0.02%	77
2025 Q3	$46.8K	Buy	557 +106	+24%	+$8.73K	0.02%	79
2025 Q2	$35.7K	Buy	451 +22	+5%	+$1.75K	0.02%	85
2025 Q1	$38.5K	Hold	429	–	–	0.02%	72
2024 Q4	$42.7K	Buy	429 +62	+17%	+$6.39K	0.02%	71
2024 Q3	$41.7K	Hold	367	–	–	0.02%	78
2024 Q2	$45.4K	Buy	+367	New	+$47.3K	0.02%	67

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Swan Capital's MRK Position: Q1 2026 in Review

Swan Capital reduced its Merck (MRK) stake by 20% in Q1 2026, selling an estimated $13K and leaving 460 shares worth $55.3K. The position accounts for 0.02% of the portfolio, ranked #74.

Swan Capital first reported a position in MRK in Q2 2024 and has held it in 8 quarters since. The position peaked at $60.3K in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Swan Capital held 460 shares of Merck worth $55.3K as of Q1 2026.
Swan Capital sold 113 Merck shares in Q1 2026, an estimated $13K.
Merck made up 0.02% of Swan Capital's portfolio in Q1 2026, its #74 holding.
Swan Capital first reported a position in Merck in Q2 2024 and has held it in 8 quarters since.
Swan Capital's Merck position peaked at $60.3K in Q4 2025.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.